SoftOx Solutions AS is a Scandinavian medtech/biotech company, founded in 2012. After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully virucidal.
The unique SoftOx technology, developed in close collaboration with expert scientists and clinicians from the universities in Skåne County and the University of Copenhagen, is based on a combination of naturally occurring chemicals that harbour broad antimicrobial effects without inducing resistance.
2012
Served areaWorldwide
10,342,871
IPOJune 1, 2018
Stock exchange(s)Euronext Oslo